TET, Pharmasset Settle Spat Over Gene Test Patent
TET Systems Holding GmbH & Co. KG and Pharmasset Inc., which develops treatments for viral infections, have reached a deal in TET Systems' infringement suit over a patent related to technology...To view the full article, register now.
Already a subscriber? Click here to view full article